Abstract:The Hippo pathway plays a critical role in organ size control in development. Deregulation of the Hippo pathway leads to drastic enlargement of organs due to increased cell proliferation, inhibition of apoptosis, and dedifferentiation of differentiated cells. Interestingly, deregulation of the Hippo pathway also plays a critical role in tumorigenesis. However, precise roles of the Hippo pathway in tumorigenesis are unclear. By generating genetically defined liver tumor-initiating cells (TICs) with Hippo pathway inactivation or YAP activation, we found that the Hippo pathway unexpectedly mediates a crosstalk between TICs and the immune system. Via cytokines induced by YAP, TICs actively recruit M2 macrophages from as early as the single-cell stage. Elimination of TIC-associated macrophages (TICAMs) abolishes tumorigenesis in a manner dependent on the immune system. Furthermore, YAP activation has been observed in TICs induced by pathologically relevant oncogenes in murine livers and in human hepatocellular carcinoma (HCC) precancerous lesions. These results demonstrate for the first time that macrophages play a decisive role in the survival of single TIC in vivo and provide a proof of principle for TIC elimination by targeting YAP or M2 macrophages. Furthermore, we found that YAP induces leukocyte-specific integrin β2 (ITGB2) expression in cancer cells, thereby promoting cell invasion through the endothelium in a manner mimicking leukocytes. Through independent biochemical purification and a functional screen, we further identified PR/SET domain 4 (PRDM4) as a transcription factor interacting with the WW domains of YAP to mediate ITGB2 expression and cell invasion. Consistently, ITGB2 and PRDM4 mRNA levels are significantly increased in metastatic prostate cancer. In addition, PRDM4 contributes to YAP-induced tumorigenesis, possibly via mediating the expression of other YAP target genes. Our results demonstrate that YAP promotes cell invasion by inducing leukocyte-specific integrin expression and identify PRDM4 as a novel transcription factor for YAP targets. Citation Format: Xiaocan Guo, Huan Liu, Xiaolei Cao, Bin Zhao. The Hippo pathway in cancer [abstract]. In: Proceedings of the AACR Special Conference on the Hippo Pathway: Signaling, Cancer, and Beyond; 2019 May 8-11; San Diego, CA. Philadelphia (PA): AACR; Mol Cancer Res 2020;18(8_Suppl):Abstract nr IA21.

Nuclear translocation of YAP drives BMI-associated hepatocarcinogenesis in hepatitis B virus infection

Nuclear Translocation of YAP Drives BMI1-associated Hepatocarcinogenesis in Hepatitis B Virus Infection

Hepatitis B Virus X Protein Modulates Oncogene Yes-Associated Protein By Creb To Promote Growth Of Hepatoma Cells

HBV Rewires Liver Cancer Signaling by Altering PP2A Complexes

The Oncoprotein HBXIP Up-Regulates YAP Through Activation of Transcription Factor C-Myb to Promote Growth of Liver Cancer.

High Mobility Group Protein B1 Controls Liver Cancer Initiation Through Yes‐associated Protein ‐dependent Aerobic Glycolysis

Hepatitis B virus X protein promotes hepatoma cell invasion and metastasis by stabilizing Snail protein

Mutual Interaction Between Yap and Creb Promotes Tumorigenesis in Liver Cancer

Hippo Inactivation Drives BMI1-associated Proliferative Hepatocarcinogenesis in Chronic Hepatitis B Virus Infection

Abstract IA21: the Hippo Pathway in Cancer

Evaluation of Yap As A Therapeutic Target in Hcc and Cca

Ablation of High‐mobility Group Box‐1 in the Liver Reduces Hepatocellular Carcinoma but Causes Hyperbilirubinemia in Hippo Signaling‐deficient Mice

Yes-associated protein/TEA domain family member and hepatocyte nuclear factor 4-alpha (HNF4α) repress reciprocally to regulate hepatocarcinogenesis in rats and mice

Phase Separation of YAP Mediated by Coiled‐coil Domain Promotes Hepatoblastoma Proliferation Via Activation of Transcription

Upregulation of CYR61 by TGF-β and YAP signaling exerts a counter-suppression of hepatocellular carcinoma

HBV Remodels PP2A Complexes to Rewire Kinase Signaling in Hepatocellular Carcinoma

Abstract 140: Distinct pathways regulated by activated β-Catenin and YAP in hepatoblastoma pathogenesis

MEK1 promotes YAP and their interaction is critical for tumorigenesis in liver cancer

HBx-induced upregulation of MAP1S drives hepatocellular carcinoma proliferation and migration via MAP1S/Smad/TGF-β1 loop

YAP-TEAD and HNF 4 α repress reciprocally to regulate hepatocarcinogenesis Running title : Hippo signaling and HNF 4 α in hepatoma

Hepatitis B Virus X Protein Promotes Human Hepatoma Cell Growth Via Upregulation of Transcription Factor AP2α and Sphingosine Kinase 1